Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14279/3605
DC FieldValueLanguage
dc.contributor.authorBrain, Joseph D.-
dc.contributor.authorChristophi, Costas A.-
dc.date.accessioned2014-07-09T07:21:03Z-
dc.date.accessioned2015-12-08T11:09:05Z-
dc.date.available2014-07-09T07:21:03Z-
dc.date.available2015-12-08T11:09:05Z-
dc.date.issued2011-05-26-
dc.identifier.citationNew England Journal of Medicine, 2011, vol. 364, no. 21, pp. 2069-2070en_US
dc.identifier.issn15334406-
dc.identifier.urihttps://hdl.handle.net/20.500.14279/3605-
dc.description.abstractAs Lal et al. (Feb. 24 issue) emphasize, α-thalassemia has profound consequences as a chronic disease that leads to anemia and multiple manifestations of iron toxicity. In an editorial in the same issue, Benz supports the conclusion that thalassemias are now more common because of globalization. Both the article and the editorial endorse newborn screening. Although we agree with the above, we also believe that primary prevention of α-thalassemia and β-thalassemia, both of which are inherited in an autosomal recessive fashion, should be recommended. In the Republic of Cyprus, the incidence of thalassemia has decreased dramatically during the past several decades, and the proportion of Cypriot babies born with β-thalassemia has decreased to less than 10% of the former level. This decrease was accomplished by increasing public awareness, counseling, prenatal diagnosis, and premarital screening, which is now required. An additional strategy is to use in vitro fertilization after prescreening to ensure that only thalassemia-free embryos are implanted.4 A complete approach to minimizing the impact of genetic diseases should include prevention as well as early diagnosis and appropriate medical interventions.en_US
dc.languageEnglishen
dc.language.isoenen_US
dc.relation.ispartofNew England Journal of Medicineen_US
dc.rights© Massachusetts Medical Societyen_US
dc.subjectAlpha-Thalassemiaen_US
dc.subjectHemoglobin Hen_US
dc.subjectHemoglobin Constant Springen_US
dc.titleHeterogeneity of hemoglobin H disease in childhooden_US
dc.typeArticleen_US
dc.collaborationHarvard Universityen_US
dc.collaborationCyprus University of Technologyen_US
dc.subject.categoryClinical Medicineen_US
dc.journalsSubscriptionen_US
dc.reviewPeer Reviewed-
dc.countryUnited Statesen_US
dc.countryCyprusen_US
dc.subject.fieldMedical and Health Sciencesen_US
dc.publicationPeer Revieweden_US
dc.identifier.doi10.1056/NEJMc1103406en_US
dc.dept.handle123456789/108en
dc.relation.issue21en_US
dc.relation.volume364en_US
cut.common.academicyear2010-2011en_US
dc.identifier.spage2069en_US
dc.identifier.epage2070en_US
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_6501-
item.openairetypearticle-
crisitem.author.deptDepartment of Rehabilitation Sciences-
crisitem.author.facultyFaculty of Health Sciences-
crisitem.author.orcid0000-0003-0503-1538-
crisitem.author.parentorgFaculty of Health Sciences-
Appears in Collections:Άρθρα/Articles
CORE Recommender
Show simple item record

SCOPUSTM   
Citations

5
checked on Nov 9, 2023

Page view(s)

486
Last Week
1
Last month
10
checked on May 24, 2024

Google ScholarTM

Check

Altmetric


Items in KTISIS are protected by copyright, with all rights reserved, unless otherwise indicated.